David Shaw’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

David Shaw’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22,627	Closed	-$132K	–	5652
2022 Q2	$132K	Buy	+22,627	New	+$128K	﹤0.01%	4672
2020 Q3	–	Sell	-5,650	Closed	-$339K	–	4256
2020 Q2	$339K	Buy	5,650 +1,815	+47%	+$166K	﹤0.01%	3573
2020 Q1	$289K	Buy	3,835 +2,377	+163%	+$274K	﹤0.01%	3487
2019 Q4	$200K	Buy	+1,458	New	+$177K	﹤0.01%	3800
2019 Q3	–	Sell	-1,690	Closed	-$236K	–	4071
2019 Q2	$236K	Buy	+1,690	New	+$297K	﹤0.01%	3404

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

David Shaw's ORTX Position: Q3 2022 in Review

David Shaw sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 22,627 shares — an estimated $132K sold.

David Shaw first reported a position in ORTX in Q2 2019 and held it in 5 quarters. The position peaked at $339K in Q2 2020. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

David Shaw reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
David Shaw sold 22,627 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022, an estimated $132K.
David Shaw first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 5 quarters.
David Shaw's Orchard Therapeutics plc American Depositary Shares position peaked at $339K in Q2 2020.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.